Allergan's Vistabel gets positive opinion from ANSM to treat crow’s feet

Allergan has received a positive opinion for its Vistabel (botulinum toxin type A) from France's Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), for the treatment of moderate to severe lateral canthal lines (crow's feet li…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news